Viral Hepatitis

In 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a major public health threat by 2030, setting out a set of targets in order to achieve this.

Our programme focuses on health systems, policy, and screening aspects of viral hepatitis, including hepatitis C virus (HCV) micro-elimination, hepatitis B virus (HBV) testing and linkage to care, and simplified and novel diagnostic tools for viral hepatitis.

Some of our current research includes:

  • HBV-COMSAVA (Hepatitis B virus COMmunity Screening and Vaccination in Africans) research project in the greater Barcelona area to test and link patients to care.
  • Hep C Free Baleares. HCV micro-elimination programme in the Balearic Islands (Mallorca, Menorca, and Ibiza).
  • The Lancet-EASL Commission on Liver Health in Europe, leading the working group on stigma.
  • Late presentation to viral hepatitis care in Spain and in Europe.
  • A global review of hepatitis C micro-elimination programmes.
  • Implementation of simplified diagnostic tools for the detection of viral hepatitis in LMICs.
  • A review of viral hepatitis testing policies.
  • Viral hepatitis policy indices (Lancet GastroHep Viral Hepaitis Commission index and Hep-CORE).

Our Team

Our team




Hepatitis B Virus COMmunity Screening and Vaccination in Africans

Hep C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.